On the Elimination of Infections Related to Oncogenic Human Papillomavirus: An Approach Using a Computational Network

Cintia Muñoz-Quiles1, Javier Díez-Domingo1, Luis Acedo2

  • 1Vaccine Research Area, FISABIO-Public Health, Avenida de Cataluña, 21, 46020 Valencia, Spain.

Viruses
|June 2, 2021
PubMed

Insights

Achieving high human papillomavirus (HPV) vaccination coverage, especially in men, is crucial for preventing cervical cancer. Models show herd immunity protects heterosexual populations, but HPV persists in men who have sex with men (MSM) without targeted strategies.

Area of Science:

  • Epidemiology
  • Public Health
  • Mathematical Modeling

Background:

  • Cervical cancer is a significant global health issue, yet preventable through HPV vaccination.
  • HPV transmission dynamics are complex, influenced by sexual behavior and network structures.

Purpose of the Study:

  • To develop and analyze an HPV transmission-dynamic model incorporating individual contact networks and MSM sexual behavior.
  • To predict the impact of varying vaccination coverage levels on HPV infection prevalence and potential elimination.

Main Methods:

  • Development of a novel HPV transmission model based on a lifetime sexual partners network.
  • Simulation of vaccination policies with 75% and 90% coverage in both sexes, including MSM.
  • Analysis of herd immunity effects and HPV persistence within different population subgroups.

Main Results:

  • Significant herd immunity observed in heterosexual networks even at 75% vaccination coverage.
  • Persistent HPV circulation noted in the men who have sex with men (MSM) population among unvaccinated individuals.
  • Approximately 75% vaccination coverage in both sexes is projected to eliminate HPV-related conditions in women within 50 years.

Conclusions:

  • High HPV vaccination coverage, particularly in men, is essential for cervical cancer prevention and HPV elimination.
  • Targeted strategies may be needed to address persistent HPV transmission in MSM populations.
  • Maintaining around 70-75% coverage in the heterosexual network offers substantial protection, but male vaccination control is key for overall elimination.